Nuvectis Pharma Inc (NASDAQ:NVCT) has a beta value of 0.45 and has seen 63332.0 shares traded in the last trading session. The company, currently valued at $129.80M, closed the last trade at $6.96 per share which meant it gained $0.17 on the day or 2.50% during that session. The NVCT stock price is -118.39% off its 52-week high price of $15.20 and 15.95% above the 52-week low of $5.85. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.16 million shares traded. The 3-month trading volume is 93.94K shares.
Nuvectis Pharma Inc (NASDAQ:NVCT) trade information
Sporting 2.50% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the NVCT stock price touched $6.96 or saw a rise of 7.2%. Year-to-date, Nuvectis Pharma Inc shares have moved -16.55%, while the 5-day performance has seen it change -1.97%. Over the past 30 days, the shares of Nuvectis Pharma Inc (NASDAQ:NVCT) have changed 12.62%. Short interest in the company has seen 0.9 million shares shorted with days to cover at 18.01.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Nuvectis Pharma Inc (NVCT) estimates and forecasts
Figures show that Nuvectis Pharma Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -34.95% over the past 6 months, with this year growth rate of 26.57%, compared to 18.00% for the industry.
NVCT Dividends
Nuvectis Pharma Inc is expected to release its next earnings report in October this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Nuvectis Pharma Inc (NASDAQ:NVCT)’s Major holders
Insiders own 53.26% of the company shares, while shares held by institutions stand at 11.44% with a share float percentage of 24.49%. Investors are also buoyed by the number of investors in a company, with Nuvectis Pharma Inc having a total of 58.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.25 million shares worth more than $1.59 million. As of 2024-06-30, VANGUARD GROUP INC held 1.5166% of shares outstanding.
The other major institutional holder is BALDWIN BROTHERS LLC/MA, with the holding of over 0.17 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.07 million and represent 1.0183% of shares outstanding.
